Humana (NYSE:HUM – Free Report) had its price objective trimmed by Barclays from $364.00 to $250.00 in a research note published on Thursday, Benzinga reports. The brokerage currently has an equal weight rating on the insurance provider’s stock. Other analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft decreased their price target on […]

Church & Dwight (NYSE:CHD – Get Free Report) had its target price raised by investment analysts at Barclays from $82.00 to $86.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s price target would indicate a potential downside of 15.36% from the company’s previous close. […]

American International Group (NYSE:AIG – Free Report) had its price objective reduced by Evercore ISI from $79.00 to $78.00 in a research report report published on Wednesday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the insurance provider’s stock. A number of other brokerages have also weighed in on AIG. StockNews.com lowered […]

W. P. Carey (NYSE:WPC – Free Report) had its target price upped by Barclays from $54.00 to $56.00 in a report released on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on the real estate investment trust’s stock. WPC has been the topic of several other research reports. Royal Bank of Canada […]

Tyson Foods (NYSE:TSN – Free Report) had its target price cut by Citigroup from $63.00 to $60.00 in a report released on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. TSN has been the topic of a number of other research reports. BMO Capital Markets increased their price objective on Tyson […]

Mastercard (NYSE:MA – Free Report) had its price objective increased by Barclays from $536.00 to $576.00 in a report released on Thursday, Benzinga reports. Barclays currently has an overweight rating on the credit services provider’s stock. Several other equities research analysts also recently weighed in on the company. Piper Sandler raised their price objective on […]

Marathon Petroleum (NYSE:MPC – Free Report) had its price objective lowered by Scotiabank from $191.00 to $170.00 in a report issued on Thursday morning, Benzinga reports. Scotiabank currently has a sector outperform rating on the oil and gas company’s stock. A number of other brokerages have also issued reports on MPC. Piper Sandler decreased their […]

DoubleVerify (NYSE:DV – Get Free Report) had its target price decreased by Barclays from $27.00 to $23.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price would indicate a potential upside of 34.66% from the company’s previous close. Other equities research […]

Science Applications International (NYSE:SAIC – Free Report) had its price target upped by Citigroup from $160.00 to $176.00 in a research report released on Thursday, Benzinga reports. They currently have a buy rating on the information technology services provider’s stock. A number of other research firms have also weighed in on SAIC. Truist Financial increased […]

Crown Castle (NYSE:CCI – Free Report) had its target price hoisted by Barclays from $112.00 to $116.00 in a report issued on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on the real estate investment trust’s stock. CCI has been the topic of a number of other research reports. Raymond James reissued […]

Willner & Heller LLC grew its stake in Humana Inc. (NYSE:HUM – Free Report) by 17.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,562 shares of the insurance provider’s stock after buying an additional 229 shares during the period. Willner […]

LyondellBasell Industries (NYSE:LYB – Get Free Report) had its target price decreased by research analysts at Royal Bank of Canada from $112.00 to $110.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the specialty chemicals company’s stock. Royal Bank of Canada’s price objective suggests a potential upside […]

Essential Properties Realty Trust (NYSE:EPRT – Get Free Report) had its price objective upped by stock analysts at Scotiabank from $30.00 to $32.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Scotiabank’s target price indicates a potential downside of 1.57% from the company’s […]

Fidelity National Information Services (NYSE:FIS – Free Report) had its target price hoisted by Barclays from $90.00 to $98.00 in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has an overweight rating on the information technology services provider’s stock. Several other equities research analysts have also recently issued reports […]

Willner & Heller LLC cut its position in Pfizer Inc. (NYSE:PFE – Free Report) by 28.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,067 shares of the biopharmaceutical company’s stock after selling 4,090 shares during the quarter. Willner & Heller LLC’s holdings […]

SBA Communications (NASDAQ:SBAC – Free Report) had its target price upped by Barclays from $236.00 to $256.00 in a report released on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the technology company’s stock. SBAC has been the topic of a number of other reports. KeyCorp upped their price objective on SBA […]

Willner & Heller LLC raised its holdings in The Cigna Group (NYSE:CI – Free Report) by 10.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 794 shares of the health services provider’s stock after acquiring an additional 73 shares during the period. Willner & Heller LLC’s holdings in The Cigna Group were […]

Willner & Heller LLC grew its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.3% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,608 shares of the medical research company’s stock after buying an additional 52 shares during the quarter. Willner […]